missing translation for 'onlineSavingsMsg'
Läs mer
Läs mer
STEMCELL Technologies JIB-04
Beskrivning
- JIB-04 is an epigenetic modifier that is a pan-selective inhibitor of Jumonji histone demethylase enzymes
- It inhibits members of the family in the high nanomolar range with IC50 values of 230, 340, 435, 445, 855 and 1100 nM for JARID1A, JMJD2E, JMJD2B, JMJD2A, JMJD3, and JMJD2C, respectively
- It shows no activity against histone deacetylases and minimal effects against iron-containing enzymes methylcytosine dioxygenase TET1 and prolyl hydroxylases (Wang et al.; Easmon et al.)
- Inhibits proliferation in a variety of human tumor cell lines (Easmon et al.)
- Selectively toxic to lung or prostate cancer cells in vitro, and not to normal cells of the same cell type or to normal control lines isolated from the same patient (Wang et al.)
- Reduces tumor burden and prolongs survival in a mouse model of breast cancer (Wang et al.)
Specifikationer
Specifikationer
| CAS | 199596-05-9 |
| Synonym | JHDM Inhibitor VII; NSC 693627 |
| Kvantitet | 10 mg |
| Molekylformel | C17H13ClN4 |
| Renhet | ≥95% |
Produkttitel
Genom att klicka på Skicka bekräftar du att du kan bli kontaktad av Fisher Scientific angående feedbacken du har lämnat i detta formulär. Vi kommer inte att dela din information för andra ändamål. All kontaktinformation som tillhandahålls ska också underhållas i enlighet med vår Sekretesspolicy.
Hittar du en möjlighet till förbättring?